The key unfavourable effect for neratinib is diarrhoea. The incidence of diarrhoea was highest during the first month of treatment. The median time to onset was 2 days and the median cumulative duration was 59 days. Whether the diarrhoea can be adequately managed by anti-diarrhoeal prophylaxis has not been established so far.